Form 4: OptimizeRx Director Receives Stock Units

OptimizeRx Corp. reports a grant of restricted stock units to Director Patrick D. Spangler, vesting in one year or at the next annual meeting.

Summary

• Patrick D. Spangler, a Director at OptimizeRx Corp., was granted 34,517 restricted stock units (RSUs) on June 9, 2026.
• These RSUs represent a contingent right to receive shares of OptimizeRx common stock.
• The RSUs will vest in full on the earlier of the first anniversary of the grant date or the date of the Company's next annual meeting of shareholders.
• Following this transaction, Spangler beneficially owns 78,732 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a standard insider equity grant for compensation and incentive purposes, rather than a significant strategic or financial development.

Positives

• Director compensation through equity awards like RSUs can align management interests with shareholder value.
• The grant of RSUs indicates continued investment and belief in the company's future prospects by a key insider.

Negatives

• The filing does not provide details on the valuation of the granted RSUs at the time of the award.

Risks

• The vesting schedule is tied to the company's next annual meeting, which could be subject to delays or changes.
• The value of the RSUs is subject to market fluctuations in OptimizeRx's stock price.

Future Outlook

The RSUs are set to vest on the earlier of the first anniversary of the grant date or the company's next annual meeting, indicating a forward-looking incentive tied to continued service and company performance.

Industry Context

StockSavvy.ai notes that equity grants to directors are a common practice in the healthcare technology sector to attract and retain talent and align incentives with long-term shareholder value creation.

Stakeholder Impact

• Shareholders: The grant of RSUs is a form of compensation, which can impact dilution if the RSUs are exercised and new shares are issued. However, it also serves to incentivize key leadership.
• Employees: Indirectly, the alignment of director incentives can contribute to overall company strategy and performance, potentially benefiting employees.
• Management: Patrick D. Spangler, as a Director, receives equity compensation that vests over time, aligning his interests with the company's long-term success.

Next Steps

• Vesting of restricted stock units on the earlier of the first anniversary of the grant date or the company's next annual meeting.

Key Dates

Keywords

OptimizeRx Corp, OPRX, Form 4, Insider Transaction, Restricted Stock Units, RSU Grant, Director Compensation, Beneficial Ownership, Patrick D. Spangler